Company page
Tryp Therapeutics, Inc.
Tryp Therapeutics, Inc. is a public company traded under the ticker 8FW in the German market. The company has a market capitalization of approximately €144.45 million. Tryp focuses on developing innovative therapies, particularly in the field of psychedelic medicine.
- Ticker
- 8FW:GETTEX
- Asset type
- Stock
- Market cap
- $162.6M
- Sector
- Industrial Services
- Industry
- Engineering & Construction
- Exchange
- GETTEX
- Currency
- EUR